Seres Therapeutics Inc
NASDAQ:MCRB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Seres Therapeutics Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Seres Therapeutics Does
Seres Therapeutics is a biotechnology company that develops therapies based on the human microbiome, the community of bacteria that live in the body. Its main products are designed to restore a healthier balance of gut microbes, especially for patients whose intestinal bacteria have been disrupted by illness or antibiotic use. The company’s best-known work has focused on treating recurrent Clostridioides difficile infection, a serious gut infection that often comes back after standard antibiotics.
- Headquarters
- United States of America US
- Employees
- 66
- IPO date
- Jun 26, 2015
Continue MCRB Research
Decided on Seres Therapeutics? Get an email when MCRB reaches the price you’d buy at. Free with an account.